Myriad Genetics: Mark Leighton, Glenn Farrell, Lisa Olson-Coombe, John Oberg, Michael Lyons

Myriad Genetics has added five senior executives in an effort to further strengthen its product roadmap and improve commercial execution. Marc Leighton, who has joined the firm as senior VP for product management, has more than 15 years of experience in healthcare and has held various product leadership roles in both global device and software, most recently as senior VP of roduct at Florence Healthcare. Glenn Farrell has been named Myriads senior VP and chief marketing officer. He has more than 25 years of experience leading brand strategy and successful go-to-market programs in healthcare, life sciences and technology, most recently as the CMO and founding team member at Sema4. Lisa Olson-Coombe is now the firm's VP of lab transformation after more than 20 years of experience in managing diagnostic lab operations, most recently as VP of laboratory operations at Exact Sciences.

John Oberg is set to join Myriad as senior VP of business development effective Jan. 3, 2023. He has more than 15 years of experience in the areas of healthcare, genomics and precision medicine, most recently serving as Head of Business Development at Invitae. Also on Jan. 3, Michael Lyons will become Myriad's general manager of oncology. Lyons boasts more than 20 years of experience in healthcare, with expertise in the oncology space. He previously served as the senior VP of North America at Novocure.